{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:36:11Z","timestamp":1761093371916,"version":"build-2065373602"},"reference-count":130,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,1,16]],"date-time":"2012-01-16T00:00:00Z","timestamp":1326672000000},"content-version":"vor","delay-in-days":2571,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2005,1]]},"abstract":"<jats:p>An increasing number of patients are developing chronic kidney disease (CKD). Appropriate care for patients with CKD must occur in the earliest stages, preferably before CKD progresses to more severe stages. Therefore, recognition and treatment of CKD and its associated complications must occur in primary care settings. Patients with CKD often have comorbid conditions such as diabetes mellitus, hypertension, and dyslipidemia, creating specific considerations when treating these diseases. Also, these patients have CKD\u2010related conditions, including anemia and renal osteodystrophy, that are not traditionally evaluated and monitored by the primary care practitioner. Collectively, many opportunities exist for pharmacists who practice in the primary care setting to improve the care of patients with CKD.<\/jats:p>","DOI":"10.1592\/phco.25.1.123.55628","type":"journal-article","created":{"date-parts":[[2004,12,16]],"date-time":"2004-12-16T10:27:43Z","timestamp":1103192863000},"page":"123-143","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Caring for Patients with Chronic Kidney Disease: A Joint Opinion of the Ambulatory Care and the Nephrology Practice and Research Networks of the American College of Clinical Pharmacy"],"prefix":"10.1002","volume":"25","author":[{"given":"Alan J.","family":"Zillich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph J.","family":"Saseen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renee M.","family":"DeHart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Dumo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darren W.","family":"Grabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Gilmartin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Hachey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna Q.","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria C.","family":"Pruchnicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie S.","family":"Joy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,16]]},"reference":[{"issue":"2","key":"e_1_2_1_2_2","first-page":"S1","article-title":"Excerpts from the USRDS 2002 annual data report: atlas of end\u2010stage renal disease in the United States","volume":"41","author":"U.S. Renal Data System.","year":"2003","journal-title":"Am J Kidney Dis"},{"volume-title":"USRDS 2000 annual data report: atlas of end\u2010stage renal disease in the United States","year":"2000","author":"U.S. Renal Data System.","key":"e_1_2_1_3_2"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(98)70145-3"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01717-5"},{"issue":"1","key":"e_1_2_1_6_2","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney disease outcome quality initiative","volume":"39","author":"National Kidney Foundation.","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70442-7"},{"issue":"4","key":"e_1_2_1_8_2","first-page":"S1","article-title":"Kidney early evaluation program","volume":"42","author":"National Kidney Foundation.","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.07104.x"},{"key":"e_1_2_1_10_2","first-page":"215","volume-title":"Primer on kidney diseases","author":"Breyer J.","year":"1998"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.46.1.223"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291401"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1988.tb01003.x"},{"key":"e_1_2_1_14_2","first-page":"190","volume-title":"Hypertension primer","author":"Andersen S.","year":"1999"},{"key":"e_1_2_1_15_2","first-page":"1007","volume-title":"Pharmacotherapy: a pathophysiologic approach","author":"Zarama M.","year":"1997"},{"issue":"2","key":"e_1_2_1_16_2","first-page":"B21","article-title":"Long\u2010term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients","volume":"23","author":"Shichiri M.","year":"2000","journal-title":"Diabetes Care"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07037-8"},{"issue":"1","key":"e_1_2_1_18_2","first-page":"S28","article-title":"Implications of the United Kingdom prospective diabetes study","volume":"26","author":"Genuth S.","year":"2003","journal-title":"Diabetes Care"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8227(95)01064-K"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.2007.S33"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07368-1"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021778"},{"issue":"1","key":"e_1_2_1_23_2","first-page":"S94","article-title":"Diabetic nephropathy","volume":"26","author":"Molitch ME","year":"2003","journal-title":"Diabetes Care"},{"issue":"1","key":"e_1_2_1_24_2","first-page":"S5","article-title":"Consensus statement on guidelines for glycemic control","volume":"8","author":"American College of Endocrinology.","year":"2002","journal-title":"Endocr Pract"},{"key":"e_1_2_1_25_2","first-page":"211","volume-title":"Hypertension primer","author":"Klag MJ.","year":"1999"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1989.37"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)70115-4"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.ndt.a027312"},{"key":"e_1_2_1_29_2","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1001\/archinte.1990.00390210059014","article-title":"The association of blood pressure levels and change in renal function in hypertensive and nonhypertensive subjects","volume":"150","author":"Rosansky SJ","year":"1990","journal-title":"Arch Intern Med"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1984.229"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03500040054036"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90638-X"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199601043340103"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.13.5_Suppl.I80"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-10-199511150-00003"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1997.260"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.19.2421"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.19.2560"},{"issue":"1","key":"e_1_2_1_39_2","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease","volume":"43","author":"Abosaif NY","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.059002702.x"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.23.2981"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-118-8-199304150-00001"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-134-5-200103060-00009"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011489"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199311113292004"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)12323-7"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)11445-8"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-2-200107170-00007"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199604113341502"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011303"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011161"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1C027"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7274.1440"},{"key":"e_1_2_1_54_2","first-page":"625","article-title":"The 2001 Canadian recommendations for the management of hypertension. II. Therapy","volume":"18","author":"McAlister FA","year":"2002","journal-title":"Can J Cardiol"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.319.7210.630"},{"key":"e_1_2_1_56_2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/ajkd.2001.22070","article-title":"Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency","volume":"37","author":"Tonelli M.","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-138-2-200301210-00010"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09327-3"},{"issue":"3","key":"e_1_2_1_59_2","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for managing dyslipidemias in chronic kidney disease","volume":"41","author":"National Kidney Foundation.","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000068461.45784.2F"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-200306000-00005"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2003.50140"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01567-X"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1159\/000065021"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.11.2152"},{"key":"e_1_2_1_66_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.5.798"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1159\/000046648"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.3109\/10641969909070853"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.12.1891"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8227(95)01138-2"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00400731"},{"key":"e_1_2_1_72_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02342442"},{"key":"e_1_2_1_73_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine1962.29.156"},{"key":"e_1_2_1_74_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.00487.x"},{"key":"e_1_2_1_75_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00284.x"},{"key":"e_1_2_1_76_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-8-200010170-00008"},{"key":"e_1_2_1_77_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000018401.82863.FD"},{"issue":"2","key":"e_1_2_1_78_2","first-page":"B 35","article-title":"Prevalence and determinants of microalbuminuria in high\u2010risk diabetic and nondiabetic patients in the heart outcomes prevention evaluation study. The HOPE study investigators","volume":"23","author":"Gerstein HC","year":"2000","journal-title":"Diabetes Care"},{"key":"e_1_2_1_79_2","first-page":"1200","article-title":"U.S. Public Health Service clinical practice guideline: treating tobacco use and dependence","volume":"45","author":"Fiore MC.","year":"2000","journal-title":"Respir Care"},{"key":"e_1_2_1_80_2","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.1996.0179"},{"key":"e_1_2_1_81_2","first-page":"266","article-title":"Are clinicians intervening with their patients who smoke? A \u201creal\u2010world\u201d assessment of 45 clinics in the upper Midwest","volume":"94","author":"Woller SC","year":"1995","journal-title":"Wis Med J"},{"key":"e_1_2_1_82_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1997.00440330047005"},{"key":"e_1_2_1_83_2","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.1990.0287"},{"key":"e_1_2_1_84_2","doi-asserted-by":"publisher","DOI":"10.1331\/108658002763538071"},{"key":"e_1_2_1_85_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.22.9.759.34073"},{"key":"e_1_2_1_86_2","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2000.109006"},{"volume-title":"Zyban (bupropion hydrochloride) package insert","year":"2004","author":"GlaxoSmithKline Pharmaceuticals.","key":"e_1_2_1_87_2"},{"key":"e_1_2_1_88_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V132504"},{"key":"e_1_2_1_89_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000070145.00225.EC"},{"key":"e_1_2_1_90_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V54.4.877.877"},{"key":"e_1_2_1_91_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.9.1621"},{"key":"e_1_2_1_92_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.suppl_11.32"},{"key":"e_1_2_1_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(96)90357-1"},{"key":"e_1_2_1_94_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.22"},{"key":"e_1_2_1_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(96)90130-4"},{"key":"e_1_2_1_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(96)90166-3"},{"key":"e_1_2_1_97_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.ndt.a027973"},{"key":"e_1_2_1_98_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03440060071035"},{"issue":"1","key":"e_1_2_1_99_2","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1016\/S0272-6386(01)70008-X","article-title":"K\/DOQI clinical practice guidelines for anemia of chronic kidney disease: update 2000","volume":"37","author":"National Kidney Foundation.","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"e_1_2_1_100_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/18.1.89"},{"key":"e_1_2_1_101_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1A416"},{"key":"e_1_2_1_102_2","first-page":"S36","article-title":"Adverse events of erythropoietin in long\u2010term and in acute\/short\u2010term treatment","volume":"72","author":"Singbartl G.","year":"1994","journal-title":"Clin Investig"},{"key":"e_1_2_1_103_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.1998.v31.pm9531176"},{"key":"e_1_2_1_104_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.25553"},{"key":"e_1_2_1_105_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V12102131"},{"key":"e_1_2_1_106_2","doi-asserted-by":"publisher","DOI":"10.1161\/hy1001.096358"},{"key":"e_1_2_1_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01781-8"},{"key":"e_1_2_1_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00111-2"},{"issue":"2","key":"e_1_2_1_109_2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-136-2-200201150-00015","article-title":"Aspirin for the primary prevention of cardiovascular events: recommendation and rationale","volume":"136","author":"U.S. Preventive Services Task Force.","year":"2001","journal-title":"Ann Intern Med"},{"issue":"8","key":"e_1_2_1_110_2","first-page":"1","article-title":"Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"52","author":"Bridges CB","year":"2003","journal-title":"MMWR Recomm Rep"},{"issue":"8","key":"e_1_2_1_111_2","first-page":"1","article-title":"Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"46","author":"Anonymous.","year":"1997","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_1_112_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-6-199903160-00002"},{"key":"e_1_2_1_113_2","doi-asserted-by":"publisher","DOI":"10.1159\/000180580"},{"key":"e_1_2_1_114_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.23.2.209.32096"},{"key":"e_1_2_1_115_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1086-5802(16)30371-0"},{"key":"e_1_2_1_116_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.12.2011"},{"key":"e_1_2_1_117_2","unstructured":"KelleyKW RamseyLA RochesterCD HoodEH HarrellTK.Management of type 2 diabetes: comparison of a specialty clinic and an internal medicine resident clinic. Presented at the 36th annual American Society of Health\u2010System Pharmacists midyear clinical meeting New Orleans LA December 26 2001."},{"key":"e_1_2_1_118_2","first-page":"785","article-title":"Physician knowledge and practice patterns relating to diabetic nephropathy","volume":"39","author":"Wong T.","year":"1999","journal-title":"J Am Pharm Assoc"},{"key":"e_1_2_1_119_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/18.1.141"},{"key":"e_1_2_1_120_2","doi-asserted-by":"publisher","DOI":"10.1159\/000190270"},{"key":"e_1_2_1_121_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.34912"},{"key":"e_1_2_1_122_2","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/ajhp\/58.21.2061","article-title":"Effectiveness of a pharmacist\u2010implemented anemia management protocol in an outpatient hemodialysis unit","volume":"58","author":"To LL","year":"2001","journal-title":"Am J Health-Syst Pharm"},{"key":"e_1_2_1_123_2","unstructured":"UeokaJ. DiBernardoJD CalescibettaCC HillTR.Pharmacist managed subcutaneous erythropoietin dose adjustment program in an outpatient hemodialysis unit. Presented at the 35th annual American Society of Health\u2010System Pharmacists midyear clinical meeting Las Vegas NV December 812 2000."},{"key":"e_1_2_1_124_2","unstructured":"BuenviajeJD ToLL StonerCP StolleySN ZieglerTW.Pilot study of an anemia management protocol at VA San Diego Healthcare System. Presented at the 35th annual American Society of Health\u2010System Pharmacists midyear clinical meeting Las Vegas NV December 812 2000."},{"key":"e_1_2_1_125_2","unstructured":"QinM. PatelPB BachDS.Impact of pharmacy services in the end\u2010stage renal disease patient. Presented at the 33rd annual American Society of Health\u2010System Pharmacists midyear clinical meeting Las Vegas NV December 610 1998."},{"key":"e_1_2_1_126_2","first-page":"1217","article-title":"Pharmacist\u2010run program optimally manages secondary hyperparathyroidism","volume":"33","author":"Anonymous.","year":"1998","journal-title":"Formulary"},{"key":"e_1_2_1_127_2","doi-asserted-by":"publisher","DOI":"10.7182\/prtr.1.9.3.j28354x695735514"},{"key":"e_1_2_1_128_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00247.x"},{"key":"e_1_2_1_129_2","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/160.11.561"},{"key":"e_1_2_1_130_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/52.17.1895"},{"key":"e_1_2_1_131_2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/ajhp\/58.2.146","article-title":"Beyond pharmaceutical manufacturer assistance: broadening the scope of an indigent drug program","volume":"58","author":"Weiner S.","year":"2001","journal-title":"Am J Health-Syst Pharm"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.25.1.123.55628","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.25.1.123.55628","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:17:09Z","timestamp":1761045429000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.25.1.123.55628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":130,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["10.1592\/phco.25.1.123.55628"],"URL":"https:\/\/doi.org\/10.1592\/phco.25.1.123.55628","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"type":"print","value":"0277-0008"},{"type":"electronic","value":"1875-9114"}],"subject":[],"published":{"date-parts":[[2005,1]]},"assertion":[{"value":"2012-01-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}